Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VVTM.V Relative to the S&P 500

VVTM.V Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the VVT Med Inc. (TSXV:VVTM.V) seasonal charts above shows that a Buy Date of May 19 and a Sell Date of August 7 has resulted in a geometric average return of 2.21% above the benchmark rate of the S&P 500 Total Return Index over the past 4 years. This seasonal timeframe has shown positive results compared to the benchmark in 4 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 4 years by an average of 35.61% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 4 years of data is available for shares of VVTM.V, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

VVT Med, Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. Its product portfolio includes ScleroSafe and V-Block, which offer several competitive advantages over traditional treatments, such as shorter procedure times, reduced patient discomfort without the need for anesthesia, and faster recovery and visible results. The company was founded in 1969 and is headquartered in Vancouver, Canada.

To download VVTM.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VVTM.V